Adalimumab (Tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina

  1. Fernandez-Bueno, I.
  2. Garcia-Gutierrez, M.T.
  3. Srivastava, G.K.
  4. Gayoso, M.J.
  5. Gonzalo-Orden, J.M.
  6. Pastor, J.C.
Revista:
Molecular Vision

ISSN: 1090-0535

Año de publicación: 2013

Volumen: 19

Páginas: 894-903

Tipo: Artículo